Articles · Biology

Testosterone Decline in Perimenopause

What testosterone does, why it falls, and how it shapes energy, libido, and drive.

7 min read · Published May 30, 2026 · Updated September 9, 2026

Sourced from peer-reviewed research and clinical guidelines, cited at the end of this article. How we write about your body.

Testosterone Decline in Perimenopause

Women carry testosterone at levels roughly 10 to 20 times lower than men, and it gets far less attention than estrogen or progesterone. Part of that is history: hormone research in women has long focused on the reproductive hormones. Part of it is that low testosterone in women does not produce a single clear syndrome with a clean cutoff the way male hypogonadism does.

What it does produce is a cluster of symptoms common in perimenopause and often blamed entirely on estrogen: low energy and motivation, low libido, less physical strength and endurance, and a flatness of mood and drive that overlaps with depression but is not the same thing. Testosterone decline contributes to all of these.

Where Women’s Testosterone Comes From

Women make testosterone from two sources. The ovaries produce about 25% directly. The adrenal glands produce dehydroepiandrosterone (DHEA) and DHEA-sulfate, which tissues like fat, skin, muscle, and liver convert into testosterone and estrogen locally.[1]

Because of this two-source system, testosterone levels are not set by the ovaries alone. Adrenal DHEA follows its own timeline: it peaks in the mid-20s and falls by about 2 to 3% a year after that, reaching roughly half its peak by the mid-50s.[2] This decline is independent of the ovaries and continues regardless of menstrual status.

The result is a gradual testosterone decline that starts in the 20s and continues into the postmenopausal years, not the abrupt drop that marks estrogen loss at menopause. By the time a woman reaches perimenopause, her testosterone has often been falling for 15 to 20 years.

What Testosterone Does in Women

Testosterone works through androgen receptors in muscle, bone, brain, skin, fat, and the reproductive organs.

Muscle mass and strength. Testosterone is anabolic: it supports protein synthesis and muscle fiber development. In women it does less of this work than in men (estrogen is anabolic too), but its slow decline feeds the loss of strength and slower recovery many women notice in their 40s.[3]

Bone density. Androgens support bone formation on their own, separate from estrogen. Women who have had both ovaries removed lose estrogen and androgen production at once, and they lose bone faster than women who go through natural menopause. That points to a testosterone contribution to bone beyond estrogen’s.[4]

Libido and sexual function. Testosterone is the main driver of sexual desire in women. The relationship is not a straight line, since desire is shaped by psychological and relationship factors too, but testosterone has a documented role in sexual motivation, genital sensitivity, and the capacity for arousal.[5] Its decline across perimenopause is one reason many women notice desire fading.

Energy, motivation, and thinking. Testosterone acts directly on dopamine pathways involved in motivation and reward. Low testosterone is linked to fatigue and reduced drive.[6] Androgen receptors in the hippocampus and prefrontal cortex suggest a role in memory and planning too, though it is unresolved whether higher testosterone protects cognition or whether healthier women simply keep higher levels.

Mood. Low testosterone in women has been linked to lower wellbeing, more depressive symptoms, and lower quality of life in some studies.[7] The effect is modest next to estrogen’s role in mood, but it matters given how many contributors overlap in perimenopause.

Identifying Low Testosterone

Testing is complicated because most testosterone in the blood is bound to sex hormone-binding globulin (SHBG) and inactive. Only free testosterone, the unbound part, reaches tissues.

Most lab assays measure total testosterone. In women, total testosterone usually runs between 0.5 and 2.4 nmol/L (15 to 70 ng/dL), though ranges vary by lab and assay. Free testosterone needs either direct measurement (less common in routine practice) or a calculation from total testosterone and SHBG.

SHBG adds another wrinkle. Estrogen raises SHBG, so as estrogen falls in perimenopause, SHBG falls too, which raises the free fraction of testosterone. Free testosterone can therefore hold relatively steady even as total testosterone drops. Women on oral estrogen-containing HRT or the combined pill have higher SHBG and lower free testosterone, which can worsen androgen-related symptoms.

There is no agreed threshold for “low” testosterone in women the way there is for men. The British Society for Sexual Medicine (BSSM) recommends basing treatment decisions on symptoms and clinical assessment rather than a single number.[8]

How Testosterone and Estrogen Interact

The perimenopausal hormone picture is not testosterone alone. Estrogen maintains genital tissue integrity, lubrication, and nerve sensitivity, which set the physical conditions for sexual function. Testosterone provides the motivation and desire. When both are falling, reduced sexual function has two reinforcing causes.

The same interaction applies to energy and mood. Serotonin and GABA function depend heavily on estrogen, while dopamine-driven drive is more androgen-dependent. A woman with flat energy and low motivation in perimenopause may be dealing with an estrogen component and an androgen component at once, which is why estrogen-only HRT does not always fully resolve these symptoms.

Women who go through surgical menopause (both ovaries removed) lose ovarian testosterone suddenly, on top of the gradual adrenal DHEA decline. This is a sharper and more severe androgen deficiency than natural menopause. Symptoms, particularly loss of libido, fatigue, and reduced wellbeing, can be more pronounced, and the evidence for testosterone therapy is strongest in this group.[9] Timing matters: treating sooner after ovary removal, before symptoms set in, is linked to better outcomes in the trial data available.

When to Raise Testosterone With a Clinician

The symptoms of low testosterone (lasting fatigue, low libido, reduced strength, flattened motivation) are common in perimenopause and often blamed entirely on estrogen. If they persist or do not improve on estrogen-based HRT, testosterone may be a separate and treatable contributor. A GP or menopause specialist can check free testosterone alongside SHBG and talk through whether androgen-directed treatment fits.

For a full overview of testosterone replacement as a treatment option, see the testosterone therapy article in the HRT section of this library.


References

[1] Burger, H. G. (2002). Androgen production in women. Fertility and Sterility, 77(Suppl 4), S3–S5. https://doi.org/10.1016/s0015-0282(02)02985-0

[2] Labrie, F., Bélanger, A., Cusan, L., Gomez, J. L., Candas, B. (1997). Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. Journal of Clinical Endocrinology and Metabolism, 82(8), 2396–2402. https://doi.org/10.1210/jcem.82.8.4160

[3] Greising, S. M., Baltgalvis, K. A., Lowe, D. A., Warren, G. L. (2009). Hormone therapy and skeletal muscle strength: A meta-analysis. Journals of Gerontology Series A, 64(10), 1071–1081. https://doi.org/10.1093/gerona/glp082

[4] Melton, L. J., Khosla, S., Malkasian, G. D., Achenbach, S. J., Oberg, A. L., Riggs, B. L. (2003). Fracture risk after bilateral oophorectomy in elderly women. Journal of Bone and Mineral Research, 18(5), 900–905. https://doi.org/10.1359/jbmr.2003.18.5.900

[5] Davis, S. R., Wahlin-Jacobsen, S. (2015). Testosterone in women: The clinical significance. Lancet Diabetes and Endocrinology, 3(12), 980–992. https://doi.org/10.1016/S2213-8587(15)00284-3

[6] Azulay Chertok, I. R., Hazan-Levi, N. (2016). The association between testosterone and wellbeing in women. Journal of Women’s Health, 25(4), 381–388.

[7] Zarrouf, F. A., Artz, S., Griffith, J., Sirbu, C., Kommor, M. (2009). Testosterone and depression: Systematic review and meta-analysis. Journal of Psychiatric Practice, 15(4), 289–305. https://doi.org/10.1097/01.pra.0000358315.88931.fc

[8] British Society for Sexual Medicine. (2019). BSSM guidelines on the management of sexual problems in women. BSSM.

[9] Shifren, J. L., Braunstein, G. D., Simon, J. A., et al. (2000). Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. New England Journal of Medicine, 343(10), 682–688. https://doi.org/10.1056/NEJM200009073431002

Teala surfaces health patterns to help you and your doctor make informed decisions. It does not diagnose conditions or replace medical advice. Always consult a qualified healthcare professional about your symptoms and treatment.